Overview
Updated 14 Jul 2026
Sumanta Kumar Pal, MD, is Professor and Vice Chair of Academic Affairs, Department of Medical Oncology & Therapeutics Research (also Chair, Kidney and Bladder Cancer Disease Team at City of Hope National Medical Center / City of Hope Comprehensive Cancer Center, Duarte, CA. The public record shows 1,404 publications with 34,788 citations (h-index 89), centered on Renal cell carcinoma treatment, Bladder and Urothelial Cancer Treatments, Cancer Immunotherapy and Biomarkers. It also documents an investigator role on 17 registered clinical trials, industry payments reported by 19 companies.
- Most recent indexed publication: 2026 · Cancer research communications
- Top research focus: Renal cell carcinoma treatment
- 17 registered trials on ClinicalTrials.gov
- Open Payments reporting from 19 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 75 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 458.
Clinical & industrytrials, payments and federal funding
Federally funded research awards.
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 17 registered studies on ClinicalTrials.gov. The most recent:
- Zanzalintinib and MO-03 for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy
Sponsor: City of Hope Medical Center
InvestigatorPhase 2Not, yet, recruitingNCT07578025 - Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell Cancer
Sponsor: City of Hope Medical Center
InvestigatorPhase 1RecruitingNCT07128680 - Nivolumab and Ipilimumab With and Without Camu Camu for the Treatment of Patients With Metastatic Renal Cell Carcinoma
Sponsor: City of Hope Medical Center
InvestigatorPhase 1Active, not recruitingNCT06049576
Industry payments
Updated 14 Jul 2026
19 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Exelixis Inc.Program year20254 payments
- Aveo Pharmaceuticals, Inc.Program year20253 payments
- Telix PharmaceuticalsProgram year20251 payment
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Comprehensive Profiling of Cell Surface Proteins in Testicular Germ Cell Tumors.
Cancer research communications
2026 - From Sequencing to Treatment: Operational Challenges in Translating Precision Oncology Into Clinical Practice.
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
2026 - Characterization of aberrant alternative splicing landscape in patients with metastatic renal cell carcinoma.
Journal for immunotherapy of cancer
2026
Most-cited worksby citation count (OpenAlex)
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →akci.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →akci.org ↗
- B.Sc./Bachelor's in Biology
California State University, Los Angeles, CONFLICTING DETAILS: AKCI bio states magna cum laude, 1998 …
1998provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →calstatela.edu ↗ - Board certified
Medical Oncology and Internal Medicine (American Board of Internal Medicine)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Editorial & leadership rolesjournal and society appointments
- Vice Chair of Academic Affairs
Department of Medical Oncology & Experimental Therapeutics, City of Hope
2023verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →oncodaily.com ↗ - Chair
Kidney and Bladder Cancer Disease Team, City of Hope
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →oncodaily.com ↗ - Co-Director
Kidney Cancer Program, City of Hope
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →akci.org ↗
Awards & honorshonors on the public record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →calstatela.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncodaily.com ↗
Secondary affiliationsappointments beyond the home institution
- President
Medical Oncology Association of Southern California (MOASC), term beginning 2026 -- MATERIAL UPDATE from prior 'Board of Directors' status, found via independent QA re-check
2026verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →oncodaily.com ↗ - Board of Directors
Medical Oncology Association of Southern California (MOASC) -- retained as historical/prior role, now superseded by Presidency above
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncodaily.com ↗
Media & interviewspress, podcasts and appearances
- Guest
ASCO Daily News podcast episode "Key Takeaways From the 2025 ASCO Quality Care Symposium" (as 'Dr. Monty Pal')
2025provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →open.spotify.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
- Host
"On the Edge of Breakthrough: Voices of Cancer Research" podcast (City of Hope)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →oncodaily.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/sumanta-pal-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/sumanta-pal-md-fasco-0927b74
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - Google Scholar
scholar.google.com/citations
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholar.google.com ↗
Mentions by otherswhere others cite or feature them
- Other
oncologytube.com/podcast-sumanta-pal-md-montypal-cityofhope-cityofhopeoc-asco22-oncotwitter-results-from-cohorts-3-4-5-of-the-cosmic-021-study
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →oncologytube.com ↗ - Other
akci.org/monty-pal
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →akci.org ↗ - Other
backtable.com/shows/urology/contributors/dr-sumanta-pal
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →backtable.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.